Presenting Author: Yu-Jung "Jenny" Wei – University of Florida
@@@ Almut G. Winterstein, PhD – Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida ### 1302738###Co-Author######Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida###Co-Author: Almut G. Winterstein, PhD – Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida
OP-3BPresenting Author: Aidan Cooper
@@@ Orla Doyle – IQVIA ### 1088162###Co-Author######IQVIA###Co-Author: Orla Doyle – IQVIA
@@@ Natalia Petruski-Ivleva – IQVIA ### 1359048###Co-Author######IQVIA###Co-Author: Natalia Petruski-Ivleva – IQVIA
@@@ Alison Bourke – IQVIA ### 1062520###Co-Author######IQVIA###Co-Author: Alison Bourke – IQVIA
SP08EPresenting Author: Claire W. Rothschild, SM
@@@ Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute ### 1062553###Co-Author###Senior Scientific Investigator###Kaiser Permanente Washington Health Research Institute###Co-Author: Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute
@@@ Jeffrey S. Brown – Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1358155###Co-Author######Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Jeffrey S. Brown – Harvard Pilgrim Health Care Institute and Harvard Medical School
@@@ Predrag Klasnja – Kaiser Permanente Washington Health Research Institute ### 1358418###Co-Author######Kaiser Permanente Washington Health Research Institute###Co-Author: Predrag Klasnja – Kaiser Permanente Washington Health Research Institute
@@@ Chayim Herzig-Marx – Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1358419###Co-Author######Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Chayim Herzig-Marx – Harvard Pilgrim Health Care Institute and Harvard Medical School
@@@ Juliane Reynolds – Harvard Pilgrim Health Care Institute and Harvard Medical Schoo ### 1358420###Co-Author######Harvard Pilgrim Health Care Institute and Harvard Medical Schoo###Co-Author: Juliane Reynolds – Harvard Pilgrim Health Care Institute and Harvard Medical Schoo
@@@ Zachary Wyner – Harvard Pilgrim Health Care Institute and Harvard Medical Schoo ### 1358421###Co-Author######Harvard Pilgrim Health Care Institute and Harvard Medical Schoo###Co-Author: Zachary Wyner – Harvard Pilgrim Health Care Institute and Harvard Medical Schoo
@@@ Christina Chambers – University of California, San Diego ### 1063135###Co-Author######University of California, San Diego###Co-Author: Christina Chambers – University of California, San Diego
@@@ David Martin, MD, MPH – Moderna ### 1360465###Co-Author###Vice President, Pharmacovigilance###Moderna###Co-Author: David Martin, MD, MPH – Moderna
SP08DPresenting Author: Costas Boussios, PhD – OM1, Inc.
@@@ Noa Palmon, BS – OM1, Inc. ### 1359516###Co-Author######OM1, Inc.###Co-Author: Noa Palmon, BS – OM1, Inc.
@@@ Cameron Jones, PhD – OM1, Inc. ### 1359517###Co-Author######OM1, Inc.###Co-Author: Cameron Jones, PhD – OM1, Inc.
@@@ Safiyy Momen, BS – OM1, Inc. ### 1359518###Co-Author######OM1, Inc.###Co-Author: Safiyy Momen, BS – OM1, Inc.
@@@ Pedro Alves, BS – OM1, Inc. ### 1359519###Co-Author######OM1, Inc.###Co-Author: Pedro Alves, BS – OM1, Inc.
@@@ Michelle B. Leavy, MPH – OM1, Inc. ### 1359244###Co-Author######OM1, Inc.###Co-Author: Michelle B. Leavy, MPH – OM1, Inc.
@@@ Gary Curhan, MD, ScD – OM1, Inc. ### 1359520###Co-Author######OM1, Inc.###Co-Author: Gary Curhan, MD, ScD – OM1, Inc.
@@@ Richard Gliklich – OM1 ### 1359521###Presenting Author######OM1###Presenting Author: Richard Gliklich – OM1
SP08GPresenting Author: Elizabeth M. Garry, PhD, MPH – Aetion, Inc
@@@ Andrew R. Weckstein, BA – Aetion, Inc ### 1358502###Co-Author###Principal Scientist###Aetion, Inc###Co-Author: Andrew R. Weckstein, BA – Aetion, Inc
@@@ Kenneth Quinto, MD, MPH – US Food and Drug Administration ### 1358485###Co-Author###Senior Medical Advisor for Real World Evidence Analytics###US Food and Drug Administration###Co-Author: Kenneth Quinto, MD, MPH – US Food and Drug Administration
@@@ Tamar Lasky, PhD, FISPE – US Food and Drug Administration ### 1046828###Co-Author###Senior Advisor on Real-world Evidence###US Food and Drug Administration###Co-Author: Tamar Lasky, PhD, FISPE – US Food and Drug Administration
@@@ Aloka Chakravarty, PhD, MStat – Food and Drug Administration ### 1358698###Co-Author###Senior Statistical Advisor###Food and Drug Administration###Co-Author: Aloka Chakravarty, PhD, MStat – Food and Drug Administration
@@@ Sandy Leonard, MPH – HealthVerity ### 1358506###Co-Author###SVP, Partnerships and Real World Data###HealthVerity###Co-Author: Sandy Leonard, MPH – HealthVerity
@@@ Sarah Vititoe, MPH – Aetion, Inc ### 1358503###Co-Author###Principal Scientist###Aetion, Inc###Co-Author: Sarah Vititoe, MPH – Aetion, Inc
@@@ Jeremy A. Rassen, ScD, FISPE – Aetion, Inc. ### 1062955###Co-Author###President and Chief Science Officer###Aetion, Inc.###Co-Author: Jeremy A. Rassen, ScD, FISPE – Aetion, Inc.
@@@ Nicolle M. Gatto, PhD, MPH, FISPE – Aetion, Inc ### 1093999###Co-Author###SVP, Scientific Research###Aetion, Inc###Co-Author: Nicolle M. Gatto, PhD, MPH, FISPE – Aetion, Inc
OP-27DPresenting Author: Hsin Min Wang – National Cheng Kung University
@@@ Edward Chia-Cheng Lai – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan ### 1358157###Co-Author###Associate Professor###School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan###Co-Author: Edward Chia-Cheng Lai – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
@@@ Kenneth K. Man PhD – Research Department of Practice and Policy, UCL School of Pharmacy, London WC1N 1AX, the United Kingdom ### 1358158###Co-Author###CW Maplethorpe Fellow###Research Department of Practice and Policy, UCL School of Pharmacy, London WC1N 1AX, the United Kingdom###Co-Author: Kenneth K. Man PhD – Research Department of Practice and Policy, UCL School of Pharmacy, London WC1N 1AX, the United Kingdom
SP02EPresenting Author: Julien Bezin – University of Bordeaux
@@@ Clément Mathieu – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France ### 1360543###Co-Author######Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France###Co-Author: Clément Mathieu – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France
@@@ Elodie Pambrun – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France ### 1360544###Co-Author######Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France###Co-Author: Elodie Pambrun – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France
@@@ Anne Benard-Laribiere – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France ### 1062911###Co-Author######Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France###Co-Author: Anne Benard-Laribiere – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France
@@@ Pernelle Noize – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, University Hospital of Bordeaux, Clinical Pharmacology, F-33000 Bordeaux, France ### 1360545###Co-Author######Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, University Hospital of Bordeaux, Clinical Pharmacology, F-33000 Bordeaux, France###Co-Author: Pernelle Noize – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, University Hospital of Bordeaux, Clinical Pharmacology, F-33000 Bordeaux, France
@@@ Marie tournier – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, Hospital Charles Perrens, F-33000 Bordeaux, France ### 1360546###Co-Author######Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, Hospital Charles Perrens, F-33000 Bordeaux, France###Co-Author: Marie tournier – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, Hospital Charles Perrens, F-33000 Bordeaux, France
@@@ Jean-Luc Faillie – Department of Medical Pharmacology and Toxicology, CHU Montpellier University Hospital, Montpellier, France; Laboratory of Biostatistics, Epidemiology and Public Health (EA 2415), Faculty of Medicine, University of Montpellier, F-34295 Montpellier, France ### 1358928###Co-Author######Department of Medical Pharmacology and Toxicology, CHU Montpellier University Hospital, Montpellier, France; Laboratory of Biostatistics, Epidemiology and Public Health (EA 2415), Faculty of Medicine, University of Montpellier, F-34295 Montpellier, France###Co-Author: Jean-Luc Faillie – Department of Medical Pharmacology and Toxicology, CHU Montpellier University Hospital, Montpellier, France; Laboratory of Biostatistics, Epidemiology and Public Health (EA 2415), Faculty of Medicine, University of Montpellier, F-34295 Montpellier, France
@@@ Antoine Pariente – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France. University Hospital of Bordeaux, Clinical Pharmacology, F-33000 Bordeaux, France ### 1358005###Co-Author######Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France. University Hospital of Bordeaux, Clinical Pharmacology, F-33000 Bordeaux, France###Co-Author: Antoine Pariente – Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France. University Hospital of Bordeaux, Clinical Pharmacology, F-33000 Bordeaux, France
OP-23EPresenting Author: Hemalkumar B. Mehta, PhD – Bloomberg School of Public Health, Johns Hopkins University
@@@ Huijun An – Johns Hopkins University ### 1358882###Co-Author###Research Analyst###Johns Hopkins University###Co-Author: Huijun An – Johns Hopkins University
@@@ Kathleen M. Andersen – Johns Hopkins Bloomberg School of Public Health ### 1063180###Co-Author###PhD Candidate###Johns Hopkins Bloomberg School of Public Health###Co-Author: Kathleen M. Andersen – Johns Hopkins Bloomberg School of Public Health
@@@ Omar Mansour, MHS – Monumental Analytics, Baltimore, MD ### 1360427###Co-Author######Monumental Analytics, Baltimore, MD###Co-Author: Omar Mansour, MHS – Monumental Analytics, Baltimore, MD
@@@ Vithal Madhira, MS – Palila Software, Reno, NV ### 1360428###Co-Author######Palila Software, Reno, NV###Co-Author: Vithal Madhira, MS – Palila Software, Reno, NV
@@@ Emaan S. Rashidi – Johns Hopkins Bloomberg School of Public Health ### 1302715###Co-Author###Masters Student###Johns Hopkins Bloomberg School of Public Health###Co-Author: Emaan S. Rashidi – Johns Hopkins Bloomberg School of Public Health
@@@ Benjamin Bates – Rutgers Robert Wood Johnson Medical School ### 1063041###Co-Author######Rutgers Robert Wood Johnson Medical School###Co-Author: Benjamin Bates – Rutgers Robert Wood Johnson Medical School
@@@ Soko Setoguchi, MD, DrPH, FISPE – RWJ Medical School, Center for Pharmacoepidemiology and Treatment Science (PETS), Institute for Health, Health Care Policy and Aging Research ### 1302720###Co-Author######RWJ Medical School, Center for Pharmacoepidemiology and Treatment Science (PETS), Institute for Health, Health Care Policy and Aging Research###Co-Author: Soko Setoguchi, MD, DrPH, FISPE – RWJ Medical School, Center for Pharmacoepidemiology and Treatment Science (PETS), Institute for Health, Health Care Policy and Aging Research
@@@ Corey Joseph, MPH – Johns Hopkins Bloomberg School of Public ### 1360429###Co-Author######Johns Hopkins Bloomberg School of Public###Co-Author: Corey Joseph, MPH – Johns Hopkins Bloomberg School of Public
@@@ Paul Kocis, PharmD, MPH – Penn State Health, Milton S. Hershey Medical Center, Hershey, PA ### 1360430###Co-Author######Penn State Health, Milton S. Hershey Medical Center, Hershey, PA###Co-Author: Paul Kocis, PharmD, MPH – Penn State Health, Milton S. Hershey Medical Center, Hershey, PA
@@@ Richard Moffitt, PhD – Stony Brook University, Stony Brook, NY ### 1360431###Co-Author######Stony Brook University, Stony Brook, NY###Co-Author: Richard Moffitt, PhD – Stony Brook University, Stony Brook, NY
@@@ Tellen D. Bennett, MD, MS – University of Colorado School of Medicine, University of Colorado, Aurora, CO ### 1360432###Co-Author######University of Colorado School of Medicine, University of Colorado, Aurora, CO###Co-Author: Tellen D. Bennett, MD, MS – University of Colorado School of Medicine, University of Colorado, Aurora, CO
@@@ Christopher Chute, MD, DrPH – Johns Hopkins University ### 1360433###Co-Author######Johns Hopkins University###Co-Author: Christopher Chute, MD, DrPH – Johns Hopkins University
@@@ Brian T. Garibaldi – Johns Hopkins Medicine ### 1302716###Co-Author###Associate Professor###Johns Hopkins Medicine###Co-Author: Brian T. Garibaldi – Johns Hopkins Medicine
@@@ G. Caleb Alexander, MD, MS – Johns Hopkins Center for Drug Safety and Effectiveness ### 1360616###Co-Author######Johns Hopkins Center for Drug Safety and Effectiveness###Co-Author: G. Caleb Alexander, MD, MS – Johns Hopkins Center for Drug Safety and Effectiveness
OP-5EPresenting Author: Nhung Thi Hong Trinh – University of Oslo
@@@ Sarah Hjorth – University of Oslo ### 1062541###Co-Author######University of Oslo###Co-Author: Sarah Hjorth – University of Oslo
@@@ Hedvig Nordeng – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo ### 1358057###Co-Author######PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo###Co-Author: Hedvig Nordeng – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo
SP14APresenting Author: Lu Chen – Genentech
@@@ Otto Fajardo – F. Hoffmann-La Roche Ltd. ### 1359988###Co-Author######F. Hoffmann-La Roche Ltd.###Co-Author: Otto Fajardo – F. Hoffmann-La Roche Ltd.
@@@ Melanie Huntley – Genentech, Inc. ### 1358147###Co-Author######Genentech, Inc.###Co-Author: Melanie Huntley – Genentech, Inc.
@@@ Anne-Marie Meyer – F. Hoffmann-La Roche Ltd. ### 1063074###Co-Author######F. Hoffmann-La Roche Ltd.###Co-Author: Anne-Marie Meyer – F. Hoffmann-La Roche Ltd.
@@@ Michael Taylor – Real World Data Collaborations, Personalized Healthcare Data Science, Genentech Inc., South San Francisco, CA, USA ### 1359989###Co-Author######Real World Data Collaborations, Personalized Healthcare Data Science, Genentech Inc., South San Francisco, CA, USA###Co-Author: Michael Taylor – Real World Data Collaborations, Personalized Healthcare Data Science, Genentech Inc., South San Francisco, CA, USA
L-3EPresenting Author: Jenny Sun – Harvard Pilgrim HeatlthCare Institute
@@@ Sengwee Toh – Harvard Medical School and Harvard Pilgrim Health Care Institute ### 1358101###Co-Author###Professor###Harvard Medical School and Harvard Pilgrim Health Care Institute###Co-Author: Sengwee Toh – Harvard Medical School and Harvard Pilgrim Health Care Institute
OP-9EPresenting Author: Mikkel Højlund, MD – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark
@@@ Lars Christian Lund, MD – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark ### 1062545###Co-Author###PhD fellow###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark###Co-Author: Lars Christian Lund, MD – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark
@@@ Kjeld Andersen, MD PhD MSc – Department of Psychiatry Odense, Mental Health Services Region of Southern Denmark ### 1360302###Co-Author###Professor###Department of Psychiatry Odense, Mental Health Services Region of Southern Denmark###Co-Author: Kjeld Andersen, MD PhD MSc – Department of Psychiatry Odense, Mental Health Services Region of Southern Denmark
@@@ Christoph U. Correll, MD – Department of Psychiatry, The Zucker Hillside Hospital ### 1360303###Co-Author###Professor###Department of Psychiatry, The Zucker Hillside Hospital###Co-Author: Christoph U. Correll, MD – Department of Psychiatry, The Zucker Hillside Hospital
@@@ Jesper Hallas, MD DMSc – University of Southern Denmark, Odense, Denmark ### 1062967###Co-Author###Professor###University of Southern Denmark, Odense, Denmark###Co-Author: Jesper Hallas, MD DMSc – University of Southern Denmark, Odense, Denmark
OP-25CPresenting Author: Shahar Shmuel, PhD – UNC Gillings School of Global Public Health
@@@ Virginia Pate – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA ### 1358426###Co-Author######Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA###Co-Author: Virginia Pate – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA
@@@ Marc J. Pepin – Durham VA Geriatric Research Education and Clinical Center (GRECC), Durham, NC 27705 USA ### 1360100###Co-Author######Durham VA Geriatric Research Education and Clinical Center (GRECC), Durham, NC 27705 USA###Co-Author: Marc J. Pepin – Durham VA Geriatric Research Education and Clinical Center (GRECC), Durham, NC 27705 USA
@@@ Janine C. Bailey – Durham VA Geriatric Research Education and Clinical Center (GRECC), Durham, NC 27705 USA ### 1360101###Co-Author######Durham VA Geriatric Research Education and Clinical Center (GRECC), Durham, NC 27705 USA###Co-Author: Janine C. Bailey – Durham VA Geriatric Research Education and Clinical Center (GRECC), Durham, NC 27705 USA
@@@ Yvonne M. Golightly – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA ### 1360103###Co-Author######Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA###Co-Author: Yvonne M. Golightly – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA
@@@ Laura C. Hanson – Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA ### 1358526###Co-Author######Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA###Co-Author: Laura C. Hanson – Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA
@@@ Til Stürmer – Department of Epidemiology, University of North Carolina at Chapel Hill ### 1062525###Co-Author######Department of Epidemiology, University of North Carolina at Chapel Hill###Co-Author: Til Stürmer – Department of Epidemiology, University of North Carolina at Chapel Hill
@@@ Rebecca B. Naumann – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA ### 1358528###Co-Author######Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA###Co-Author: Rebecca B. Naumann – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA
@@@ Danijela Gnjidic – Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia ### 1360105###Co-Author######Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia###Co-Author: Danijela Gnjidic – Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
@@@ Jennifer L. Lund, PhD – Department of Epidemiology, University of North Carolina at Chapel Hill ### 1062592###Co-Author###Associate Professor###Department of Epidemiology, University of North Carolina at Chapel Hill###Co-Author: Jennifer L. Lund, PhD – Department of Epidemiology, University of North Carolina at Chapel Hill
OP-3CPresenting Author: Sara Levintow
@@@ Kate Orroth – Amgen Inc. ### 1358779###Co-Author######Amgen Inc.###Co-Author: Kate Orroth – Amgen Inc.
@@@ Alexander Breskin – NoviSci Inc. ### 1062519###Co-Author######NoviSci Inc.###Co-Author: Alexander Breskin – NoviSci Inc.
@@@ Paul Dluzniewski – Amgen Inc. ### 1358783###Co-Author######Amgen Inc.###Co-Author: Paul Dluzniewski – Amgen Inc.
@@@ Andrew Park – Center for Observational Research, Amgen ### 1358536###Co-Author######Center for Observational Research, Amgen###Co-Author: Andrew Park – Center for Observational Research, Amgen
@@@ M. Alan Brookhart – NoviSci, Inc. ### 1358200###Co-Author######NoviSci, Inc.###Co-Author: M. Alan Brookhart – NoviSci, Inc.
SP06EPresenting Author: Marion Lassalle – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France.
@@@ Thien Le Tri – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France ### 1360202###Co-Author######EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France###Co-Author: Thien Le Tri – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France
@@@ Pauline Afchain – APHP, Hôpital Saint Antoine, Medical Oncology Department, Paris, France ### 1360203###Co-Author######APHP, Hôpital Saint Antoine, Medical Oncology Department, Paris, France###Co-Author: Pauline Afchain – APHP, Hôpital Saint Antoine, Medical Oncology Department, Paris, France
@@@ Marine Camus-Duboc – Sorbonne Université, Centre de Recherche Saint Antoine, UMRS-938, Paris, France ### 1360204###Co-Author######Sorbonne Université, Centre de Recherche Saint Antoine, UMRS-938, Paris, France###Co-Author: Marine Camus-Duboc – Sorbonne Université, Centre de Recherche Saint Antoine, UMRS-938, Paris, France
@@@ Julien Kirchgesner – Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France ### 1358599###Co-Author###Visiting researcher###Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France###Co-Author: Julien Kirchgesner – Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France
@@@ Mahmoud Zureik – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance) ### 1358633###Co-Author######EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance)###Co-Author: Mahmoud Zureik – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance)
@@@ Rosemary Dray-Spira – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France ### 1093512###Co-Author######EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France###Co-Author: Rosemary Dray-Spira – EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France
OP-1FPresenting Author: Julius Asubonteng – Gilead Science Inc.,
@@@ Sara Haredasht – Gilead Science Inc., ### 1360399###Co-Author######Gilead Science Inc.,###Co-Author: Sara Haredasht – Gilead Science Inc.,
@@@ Seth Kuranz – Trinetx Inc., ### 1062896###Co-Author######Trinetx Inc.,###Co-Author: Seth Kuranz – Trinetx Inc.,
@@@ Anand Chokkalingam – Gilead Science Inc., ### 1360400###Co-Author######Gilead Science Inc.,###Co-Author: Anand Chokkalingam – Gilead Science Inc.,
L-1APresenting Author: Elizabeth A. Suarez – Brigham and Women's Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics
@@@ Michael Nguyen, MD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1360257###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###Co-Author: Michael Nguyen, MD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
@@@ Di Zhang – Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, MD ### 1360258###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, MD###Co-Author: Di Zhang – Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, MD
@@@ Yueqin Zhao – Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, MD ### 1359918###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, MD###Co-Author: Yueqin Zhao – Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, MD
@@@ Danijela Stojanovic – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1359917###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###Co-Author: Danijela Stojanovic – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
@@@ Monica A. Munoz, PharmD, PhD – Division of Pharmacovigilance, Center for Drug Evaluation and Research, US Food and Drug Administration; Silver Spring, MD ### 1358805###Co-Author###Deputy Director###Division of Pharmacovigilance, Center for Drug Evaluation and Research, US Food and Drug Administration; Silver Spring, MD###Co-Author: Monica A. Munoz, PharmD, PhD – Division of Pharmacovigilance, Center for Drug Evaluation and Research, US Food and Drug Administration; Silver Spring, MD
@@@ Jane Liedtka, MD, Board certified dermatologist – Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD ### 1360259###Co-Author###Medical Officer###Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD###Co-Author: Jane Liedtka, MD, Board certified dermatologist – Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD
@@@ Abby F. Anderson, M.D. – Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD ### 1360260###Co-Author###Medical Officer###Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD###Co-Author: Abby F. Anderson, M.D. – Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD
@@@ Wei Liu – Division of Epidemiology, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD ### 1358274###Co-Author######Division of Epidemiology, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD###Co-Author: Wei Liu – Division of Epidemiology, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD
@@@ Inna Dashevsky – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA ### 1360261###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA###Co-Author: Inna Dashevsky – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
@@@ David V. Cole – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA ### 1360262###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA###Co-Author: David V. Cole – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
@@@ Sandra DeLuccia – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA ### 1360263###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA###Co-Author: Sandra DeLuccia – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
@@@ Talia Menzin – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA ### 1360264###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA###Co-Author: Talia Menzin – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
@@@ Jennifer Noble – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA ### 1360265###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA###Co-Author: Jennifer Noble – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
@@@ Judith C. Maro, PhD – Harvard Pilgrim Health Care Institute ### 1062626###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Judith C. Maro, PhD – Harvard Pilgrim Health Care Institute
OP-19FPresenting Author: Michael Webster-Clark – University of North Carolina at Chapel Hill
@@@ Jennifer L. Lund, PhD – Department of Epidemiology, University of North Carolina at Chapel Hill ### 1062592###Co-Author###Associate Professor###Department of Epidemiology, University of North Carolina at Chapel Hill###Co-Author: Jennifer L. Lund, PhD – Department of Epidemiology, University of North Carolina at Chapel Hill
@@@ Hanna Sanoff – University of North Carolina at Chapel Hill Department of Medicine ### 1358646###Co-Author###Associate Professor###University of North Carolina at Chapel Hill Department of Medicine###Co-Author: Hanna Sanoff – University of North Carolina at Chapel Hill Department of Medicine
@@@ Til Stürmer – Department of Epidemiology, University of North Carolina at Chapel Hill ### 1062525###Co-Author######Department of Epidemiology, University of North Carolina at Chapel Hill###Co-Author: Til Stürmer – Department of Epidemiology, University of North Carolina at Chapel Hill
@@@ Daniel Westreich – University of North Carolina at Chapel Hill ### 1358642###Co-Author######University of North Carolina at Chapel Hill###Co-Author: Daniel Westreich – University of North Carolina at Chapel Hill
@@@ Alexander Keil – University of North Carolina at Chapel Hill ### 1358641###Co-Author######University of North Carolina at Chapel Hill###Co-Author: Alexander Keil – University of North Carolina at Chapel Hill
OP-24APresenter: Laura Hester, PhD, MS – Janssen Pharmaceuticals, Inc.
@@@ Donna R. Rivera, PharmD, MSc – US Food and Drug Administration ### 1358504###Presenter######US Food and Drug Administration###Presenter: Donna R. Rivera, PharmD, MSc – US Food and Drug Administration
@@@ Jennifer L. Lund, PhD – Department of Epidemiology, University of North Carolina at Chapel Hill ### 1062592###Presenter###Associate Professor###Department of Epidemiology, University of North Carolina at Chapel Hill###Presenter: Jennifer L. Lund, PhD – Department of Epidemiology, University of North Carolina at Chapel Hill
@@@ Asieh Golozar, MD, PhD, MHS, MPH – Regeneron Pharmaceuticals ### 1062692###Presenter######Regeneron Pharmaceuticals###Presenter: Asieh Golozar, MD, PhD, MHS, MPH – Regeneron Pharmaceuticals
@@@ Kourtney Davis – Janssen R&D, LLC ### 1360502###Presenter###Senior Director###Janssen R&D, LLC###Presenter: Kourtney Davis – Janssen R&D, LLC
@@@ John D. Seeger, PharmD, FISPE – Optum Epidemiology ### 1046832###Presenter######Optum Epidemiology###Presenter: John D. Seeger, PharmD, FISPE – Optum Epidemiology
@@@ Leah Sansbury – Ultragenyx Pharmaceuticals Inc ### 1088146###Presenter######Ultragenyx Pharmaceuticals Inc###Presenter: Leah Sansbury – Ultragenyx Pharmaceuticals Inc
WS-20Presenting Author: Jodie Hillen, MClinE, PhD, BPharm – University of South Australia
@@@ Michael Ward – University of South Australia ### 1359331###Co-Author######University of South Australia###Co-Author: Michael Ward – University of South Australia
@@@ Mark Slee – Flinders University ### 1359332###Co-Author######Flinders University###Co-Author: Mark Slee – Flinders University
@@@ Ty Stanford ### 1358336###Co-Author#########Co-Author: Ty Stanford
@@@ Elizabeth E. Roughead – Clinical and Health Sciences, University of South Australia ### 1358679###Co-Author######Clinical and Health Sciences, University of South Australia###Co-Author: Elizabeth E. Roughead – Clinical and Health Sciences, University of South Australia
@@@ Lisa Kalisch-Ellett – University of South Australia ### 1086973###Co-Author######University of South Australia###Co-Author: Lisa Kalisch-Ellett – University of South Australia
@@@ Nicole Pratt – University of South Australia ### 1358335###Co-Author######University of South Australia###Co-Author: Nicole Pratt – University of South Australia
SP03FPresenting Author: James Heyward, MPH – Johns Hopkins Center for Drug Safety and Effectiveness
@@@ Kathryn Foti, PhD, MPH – Johns Hopkins Center for Drug Safety and Effectiveness ### 1360611###Co-Author######Johns Hopkins Center for Drug Safety and Effectiveness###Co-Author: Kathryn Foti, PhD, MPH – Johns Hopkins Center for Drug Safety and Effectiveness
@@@ Matthew Tajanlangit – Johns Hopkins Center for Drug Safety and Effectiveness ### 1360612###Co-Author######Johns Hopkins Center for Drug Safety and Effectiveness###Co-Author: Matthew Tajanlangit – Johns Hopkins Center for Drug Safety and Effectiveness
@@@ Kristin Meek, BA – Johns Hopkins Center for Drug Safety and Effectiveness ### 1360613###Co-Author######Johns Hopkins Center for Drug Safety and Effectiveness###Co-Author: Kristin Meek, BA – Johns Hopkins Center for Drug Safety and Effectiveness
@@@ Christopher Jones, PharmD, DrPH – Centers for Disease Control and Prevention ### 1360614###Co-Author######Centers for Disease Control and Prevention###Co-Author: Christopher Jones, PharmD, DrPH – Centers for Disease Control and Prevention
@@@ Andrew Kolodny, MD – Brandeis University ### 1360615###Co-Author######Brandeis University###Co-Author: Andrew Kolodny, MD – Brandeis University
@@@ G. Caleb Alexander, MD, MS – Johns Hopkins Center for Drug Safety and Effectiveness ### 1360616###Co-Author######Johns Hopkins Center for Drug Safety and Effectiveness###Co-Author: G. Caleb Alexander, MD, MS – Johns Hopkins Center for Drug Safety and Effectiveness
OP-6APresenting Author: Kathleen M. Andersen – Johns Hopkins Bloomberg School of Public Health
@@@ Emaan S. Rashidi – Johns Hopkins Bloomberg School of Public Health ### 1302715###Co-Author###Masters Student###Johns Hopkins Bloomberg School of Public Health###Co-Author: Emaan S. Rashidi – Johns Hopkins Bloomberg School of Public Health
@@@ Huijun An – Johns Hopkins University ### 1358882###Co-Author###Research Analyst###Johns Hopkins University###Co-Author: Huijun An – Johns Hopkins University
@@@ Hemalkumar B. Mehta, PhD – Bloomberg School of Public Health, Johns Hopkins University ### 1093588###Co-Author###Assistant Professor###Bloomberg School of Public Health, Johns Hopkins University###Co-Author: Hemalkumar B. Mehta, PhD – Bloomberg School of Public Health, Johns Hopkins University
@@@ Derek K. Ng – Johns Hopkins Bloomberg School of Public Health ### 1360381###Co-Author###Assistant Professor###Johns Hopkins Bloomberg School of Public Health###Co-Author: Derek K. Ng – Johns Hopkins Bloomberg School of Public Health
@@@ Brian T. Garibaldi – Johns Hopkins Medicine ### 1302716###Co-Author###Associate Professor###Johns Hopkins Medicine###Co-Author: Brian T. Garibaldi – Johns Hopkins Medicine
@@@ Jodi B. Segal – Johns Hopkins University ### 1302718###Co-Author###Professor###Johns Hopkins University###Co-Author: Jodi B. Segal – Johns Hopkins University
@@@ G. Caleb Alexander, MD, MS – Johns Hopkins Center for Drug Safety and Effectiveness ### 1360616###Co-Author######Johns Hopkins Center for Drug Safety and Effectiveness###Co-Author: G. Caleb Alexander, MD, MS – Johns Hopkins Center for Drug Safety and Effectiveness
OP-4C